Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53–MDM2 Interaction Useful in Targeted Cancer Therapy

被引：0
|
作者：
Alpana K. Gupta
Mausumi Bharadwaj
Anoop Kumar
Ravi Mehrotra
机构：
[1] National Institute of Cancer Prevention and Research (ICMR),Division of Molecular Cytology, Department of Health Research (Govt. of India)
[2] National Institute of Cancer Prevention and Research (ICMR),Division of Molecular Genetics and Biochemistry
来源：
Topics in Current Chemistry | 2017年 / 375卷
关键词：
p53–MDM2 interaction; Small molecule inhibitors; Spiro-oxindoles; Anticancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy
    Gupta, Alpana K.
    Bharadwaj, Mausumi
    Kumar, Anoop
    Mehrotra, Ravi
    TOPICS IN CURRENT CHEMISTRY, 2017, 375 (01)
  • [2] Small molecule inhibitors of p53/MDM2 interaction
    Fotouhi, N
    Graves, B
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 159 - 165
  • [3] Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction
    Ding, Ke
    Lu, Yipin
    Nikolovska-Coleska, Zaneta
    Wang, Guoping
    Qiu, Su
    Shangary, Sanjeev
    Gao, Wei
    Qin, Dongguang
    Stuckey, Jeanne
    Krajewski, Krzysztof
    Roller, Peter P.
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) : 3432 - 3435
  • [4] Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
    Haohao Zhu
    Hui Gao
    Yingying Ji
    Qin Zhou
    Zhiqiang Du
    Lin Tian
    Ying Jiang
    Kun Yao
    Zhenhe Zhou
    Journal of Hematology & Oncology, 15
  • [5] Molecular Docking, QSAR and Molecular Dynamics Simulation on Spiro-oxindoles as MDM2 Inhibitors
    Li Bo
    Zhou Rui
    He Gu
    Guo Li
    Huang Wei
    ACTA CHIMICA SINICA, 2013, 71 (10) : 1396 - 1403
  • [6] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [7] Reactivation of p53 by novel MDM2 inhibitors for pancreatic cancer therapy
    Azmi, Asfar
    Philip, Philip
    Wang, Zhiwei
    Ahmad, Aamir
    Wu, Jiusheng
    Aboukameel, Amro
    Yang, Dajun
    Wang, Shaomeng
    Sarkar, Fazlul
    Mohammad, Ramzi
    CANCER RESEARCH, 2009, 69
  • [8] Inhibiting the p53–MDM2 interaction: an important target for cancer therapy
    Patrick Chène
    Nature Reviews Cancer, 2003, 3 : 102 - 109
  • [9] MDM2 inhibitors to reactivate p53 in human cancer
    Vassilev, L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S6 - S6
  • [10] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
12345